JAN 23, 2020 5:11 PM PST

The role of circular RNA in melanoma

New research published in the journal Cancer Cell investigates the role of circular RNAs in the spread of melanoma. Melanoma is a particularly aggressive cancer, with metastasis growing from primary tumors of only a few millimeters. For this reason, the research team behind the new study decided to use melanoma to consider how and why metastatic spread occurs. Understanding this is crucial because metastasis is the cause of 90% of deaths related to cancer.

The functions of circular RNAs (circRNAs) have not been fully understood, so researcher Eva Hernando, Ph.D., an associate professor in the Department of Pathology at New York University (NYU) Langone Health, decided to find out how circRNA can drive or stop metastasis. Along with her colleagues, she conducted experiments in mouse models as well as in cell cultures from human melanoma tissues to determine the role of circRNAs in metastasis.

The team found that a circRNA called CDR1as plays a significant role in metastasis. As Medical News Today reports, “When epigenetically silenced, this molecule promotes the spread of cancer, and when activated, it inhibits cancer's aggressive spread.”

"Our study provides new insights into the aggressive behavior of melanoma, and [it] is the first to expose a circRNA as a suppressor of metastasis," commented Hernando.

The suppressor mechanism works because an activated CDR1 connects with the RNA-binding protein IGF2BP3 and stops it from binding to pro-metastatic proteins. Meanwhile, a shut-off CDR1as allows IGF2BP3 to bind as it wants to thus promote metastasis.

Scientists are still trying to figure out the functions of circular RNA. Photo: Pixabay

This finding has potential implications for future therapies, explains first study author Douglas Hanniford, Ph.D., an instructor in the Department of Pathology at NYU Langone Health. "We found CDR1as restrains a known pro-cancer protein called IGF2BP3, revealing a new function of CDR1as that may have therapeutic implications."

Sources: Cancer Cell, Medical News Today

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
APR 25, 2020
Cancer
APR 25, 2020
Breaking the Blood-Brain Barrier in the Fight Against Brain Cancer
One of the more unique aspects of the human body is the blood-brain barrier (BBB) that protects the central nervous syst ...
APR 24, 2020
Drug Discovery & Development
APR 24, 2020
Drug Targets Hard To Treat Uterine Cancer
A clinical trial was deemed successful when evaluating a therapeutic for a hard-to-treat form of uterine cancer. The dru ...
APR 28, 2020
Cancer
APR 28, 2020
Is a multi-cancer detection blood test safe for women?
Earlier detection is essential in order to reduce deaths caused by cancer. A new study, DETECT-A (Detecting cancers Earl ...
JUN 10, 2020
Drug Discovery & Development
JUN 10, 2020
A Highly Targeted Cancer Therapeutic
A study led by researchers at USC School of Pharmacy discusses a way to engineer drugs that highly target malignant tiss ...
JUN 24, 2020
Cancer
JUN 24, 2020
Even low levels of air pollution are associated with morbidity
A new study investigates the causal relationship between mortality and long-term exposure to a low level of fine particu ...
JUN 30, 2020
Cancer
JUN 30, 2020
PAR glycohydrolase inhibitors to enhance treatment for gliomas
New hope for glioma patients comes in the form of a novel strategy to target tumors, the results of which are published ...
Loading Comments...